Volatile Week, but Green? Click to watch the new Podcast.

Akebia Therapeutics Stock Forecast

NASDAQ:AKBA BUY SELL

$0.41 (5.14%)

Volume: 16.216M

Closed: Jul 05, 2022

Hollow Logo Score: 0.357

Akebia Therapeutics Stock Forecast

BUY SELL NASDAQ:AKBA
$0.41 (5.14%)

Volume: 16.216M

Closed: Jul 05, 2022

Score Hollow Logo 0.357

Akebia Therapeutics Stock Price (Quote) NASDAQ:AKBA

$0.41 ( 5.14% ) Tuesday, 5th Jul 2022

Range Low Price High Price Comment
30 days $0.30 $0.51 Tuesday, 5th Jul 2022 AKBA stock ended at $0.41. This is 5.14% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 12.58% from a day low at $0.38 to a day high of $0.43.
90 days $0.30 $0.60
52 weeks $0.30 $3.71

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
2022-07-05 $0.39 $0.43 $0.38 $0.41 16 216 309
2022-07-01 $0.49 $0.50 $0.38 $0.39 74 315 155
2022-06-30 $0.35 $0.36 $0.34 $0.35 24 682 362
2022-06-29 $0.46 $0.51 $0.36 $0.38 84 320 752
2022-06-28 $0.37 $0.38 $0.35 $0.35 3 716 188
2022-06-27 $0.37 $0.38 $0.34 $0.37 5 343 154
2022-06-24 $0.40 $0.41 $0.36 $0.37 24 016 776
2022-06-23 $0.35 $0.40 $0.35 $0.39 7 831 990
2022-06-22 $0.33 $0.37 $0.33 $0.36 7 100 082
2022-06-21 $0.35 $0.36 $0.32 $0.35 9 162 362
2022-06-17 $0.32 $0.36 $0.31 $0.34 21 186 574
2022-06-16 $0.34 $0.35 $0.30 $0.32 18 237 173
2022-06-15 $0.39 $0.40 $0.33 $0.35 24 566 034
2022-06-14 $0.38 $0.38 $0.33 $0.35 4 009 232
2022-06-13 $0.39 $0.40 $0.36 $0.37 6 034 907
2022-06-10 $0.42 $0.43 $0.39 $0.41 6 104 490
2022-06-09 $0.45 $0.46 $0.42 $0.44 5 356 145
2022-06-08 $0.43 $0.46 $0.42 $0.45 6 526 940
2022-06-07 $0.37 $0.44 $0.37 $0.43 10 546 468
2022-06-06 $0.41 $0.42 $0.36 $0.38 9 875 577
2022-06-03 $0.35 $0.41 $0.35 $0.41 7 114 357
2022-06-02 $0.35 $0.36 $0.33 $0.36 4 614 965
2022-06-01 $0.39 $0.39 $0.34 $0.35 7 517 395
2022-05-31 $0.37 $0.41 $0.36 $0.37 9 003 612
2022-05-27 $0.34 $0.37 $0.33 $0.37 7 984 476
2022-05-26 $0.33 $0.36 $0.33 $0.34 8 652 389
2022-05-25 $0.32 $0.34 $0.31 $0.33 5 372 901
2022-05-24 $0.32 $0.33 $0.30 $0.32 7 303 044
2022-05-23 $0.33 $0.34 $0.31 $0.32 9 320 406
2022-05-20 $0.36 $0.37 $0.31 $0.33 11 510 540
2022-05-19 $0.34 $0.37 $0.32 $0.35 6 913 201
2022-05-18 $0.36 $0.38 $0.32 $0.33 11 893 265
2022-05-17 $0.39 $0.39 $0.36 $0.37 9 262 667
2022-05-16 $0.36 $0.39 $0.35 $0.38 10 619 319
2022-05-13 $0.42 $0.45 $0.42 $0.45 8 074 676
2022-05-12 $0.40 $0.43 $0.39 $0.41 9 530 078
2022-05-11 $0.41 $0.45 $0.40 $0.42 9 752 625
2022-05-10 $0.38 $0.45 $0.38 $0.43 17 562 885
2022-05-09 $0.37 $0.39 $0.35 $0.35 9 344 550
2022-05-06 $0.40 $0.42 $0.38 $0.38 8 451 649
2022-05-05 $0.42 $0.44 $0.41 $0.41 7 310 325
2022-05-04 $0.43 $0.44 $0.40 $0.44 6 438 522
2022-05-03 $0.42 $0.45 $0.42 $0.43 7 597 120
2022-05-02 $0.41 $0.43 $0.40 $0.43 11 050 696
2022-04-29 $0.42 $0.44 $0.41 $0.42 6 298 479
2022-04-28 $0.42 $0.44 $0.40 $0.42 8 279 311
2022-04-27 $0.45 $0.47 $0.42 $0.43 10 632 440
2022-04-26 $0.47 $0.47 $0.44 $0.45 8 460 635
2022-04-25 $0.47 $0.48 $0.45 $0.47 8 448 804
2022-04-22 $0.48 $0.50 $0.46 $0.48 4 995 420

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 26 218 stocks, only a few dozen will trigger such a signal!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. Its lead product candidate is vadadustat, an oral therapy which has completed a Phase II study for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients; and clinical product candidate is ... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT